ArticleOrphanet journal of rare diseases2024
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
Shahram Attarian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.